Green Lifescience Co., Ltd. (KOSDAQ:114450)
1,868.00
+141.00 (8.16%)
At close: Jun 29, 2026
Green Lifescience Revenue
Green Lifescience had revenue of 15.55B KRW in the quarter ending March 31, 2026, with 219.16% growth. This brings the company's revenue in the last twelve months to 51.02B, up 119.98% year-over-year. In the year 2025, Green Lifescience had annual revenue of 40.34B with 62.26% growth.
Revenue (ttm)
51.02B
Revenue Growth
+119.98%
P/S Ratio
0.71
Revenue / Employee
728.81M
Employees
70
Market Cap
36.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 40.34B | 15.48B | 62.26% |
| Dec 31, 2024 | 24.86B | 2.49B | 11.14% |
| Dec 31, 2023 | 22.37B | -14.14B | -38.72% |
| Dec 31, 2022 | 36.50B | 11.17B | 44.07% |
| Dec 31, 2021 | 25.34B | 776.97M | 3.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KB Autosys | 221.17B |
| Q Capital Partners | 117.56B |
| Green Plus | 115.20B |
| BORATR CO. | 105.14B |
| NEXTURN&ROLLKOREA | 89.51B |
| NHN BUGS | 67.03B |
| Mr. Blue | 66.83B |
| N2Tech Co.,Ltd | 30.92B |